International Journal of Cancer, 101 (1), 7-10
Heart conditions: besides the TMAO cardiovascular risk there is also a potential for interactions with heart medications Kidney disease: impaired clearance can lead to accumulation and toxicity Diabetes: L-carnitine may affect blood sugar levels , requiring medication adjustments Thyroid disorders: particularly hypothyroidism, as L-carnitine inhibits thyroid hormone action at the cellular level, which can worsen fatigue and metabolic symptoms in hypothyroid patients Seizure disorders: risk of lowering seizure threshold Better (and Proven) Alternatives to Approach Weight Loss Lets acknowledge one thing up front: its easy to get drawn in by quick fixesespecially with all the glowing online reviews of trendy supplements like b12-shots or creatine , upping the hype
Lexaria has been actively evaluating DehydraTECH across multiple therapeutic areas since 2015, with a recent focus on applying the platform to GLP-1 drugs
A protective effect of GLP-1 agonists on blood vessels has been demonstrated, as evidenced by the reduction of non-fatal and fatal stroke incidence by 15% and 19%, respectively, in patients with T2DM treated with GLP-1 agonists [43]
no more than 1 dose per 24 hours and 8 doses per month [1] [3]
References Koletzko B, Baker S, Cleghorn G, et al (2005)